Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study.
about
Skeletal adverse effects with aromatase inhibitors in early breast cancer: evidence to date and clinical guidanceVitamin D in the cancer patientCalcium and vitamin D supplementation and loss of bone mineral density in women undergoing breast cancer therapy.Postmenopausal Breast Cancer, Aromatase Inhibitors, and Bone Health: What the Surgeon Should Know.Phytotherapy and Nutritional Supplements on Breast CancerBone health in long-term gastric cancer survivors: A prospective study of high-dose vitamin D supplementation using an easy administration scheme.
P2860
Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Vitamin D threshold to prevent ...... ABLE prospective cohort study.
@en
Vitamin D threshold to prevent ...... ABLE prospective cohort study.
@nl
type
label
Vitamin D threshold to prevent ...... ABLE prospective cohort study.
@en
Vitamin D threshold to prevent ...... ABLE prospective cohort study.
@nl
prefLabel
Vitamin D threshold to prevent ...... ABLE prospective cohort study.
@en
Vitamin D threshold to prevent ...... ABLE prospective cohort study.
@nl
P2093
P2860
P50
P1476
Vitamin D threshold to prevent ...... -ABLE prospective cohort study
@en
P2093
Ignasi Tusquets
Joan Albanell
Laia Garrigós
Nigel K Arden
Sonia Servitja
P2860
P2888
P304
P356
10.1007/S10549-012-2013-9
P407
P577
2012-03-21T00:00:00Z